Why the study?
How should patients with cocaine-associated myocardial ischaemia be treated compared to those with ischaemia unrelated to cocaine?
How should patients with cocaine-associated myocardial ischaemia be treated compared to those with ischaemia unrelated to cocaine?
Cocaine-associated myocardial infarction requires specific management including benzodiazepines and avoidance of beta-blockers to prevent worsening coronary vasoconstriction.
Highlights need for cocaine-specific ACS protocols; leaves open prospective validation of current recommendations.
Myocardial ischaemia and infarction has become a well-recognized sequelae of cocaine use. The possibility of recent cocaine use should be assessed in patients with potential myocardial ischaemia because the treatment of patients with myocardial ischaemia related to cocaine differs from that of patients with myocardial ischaemia unrelated to cocaine. Patients with cocaine-associated myocardial ischaemia should receive initial treatment with benzodiazepines to decrease central adrenergic stimulation. Aspirin should be used to reduce thrombus formation, and nitroglycerin to reverse coronary vasoconstriction. Patients with continued ischaemia can be treated with either low doses of phentolamine, or verapamil. If ischaemia continues after treatment with these agents mechanical reperfusion or thrombolytic therapy should be considered depending upon the clinical circumstances. Patients with myocardial ischaemia secondary to cocaine should not receive treatment with beta adrenergic antagonists as these agents enhance coronary vasoconstriction thereby worsening ischaemia.
No takes yet. Share an insight, caveat, or question.
Judd E. Hollander (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: